chr12-6514538-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014865.4(NCAPD2):āc.790C>Gā(p.Leu264Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCAPD2 | NM_014865.4 | c.790C>G | p.Leu264Val | missense_variant | 8/32 | ENST00000315579.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCAPD2 | ENST00000315579.10 | c.790C>G | p.Leu264Val | missense_variant | 8/32 | 1 | NM_014865.4 | P1 | |
NCAPD2 | ENST00000382457.8 | c.406C>G | p.Leu136Val | missense_variant | 5/21 | 5 | |||
NCAPD2 | ENST00000545732.1 | n.302C>G | non_coding_transcript_exon_variant | 2/4 | 5 | ||||
NCAPD2 | ENST00000539084.5 | c.*485C>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/31 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251430Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135890
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461888Hom.: 0 Cov.: 34 AF XY: 0.0000371 AC XY: 27AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 18, 2022 | The c.790C>G (p.L264V) alteration is located in exon 8 (coding exon 7) of the NCAPD2 gene. This alteration results from a C to G substitution at nucleotide position 790, causing the leucine (L) at amino acid position 264 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at